Your browser is no longer supported. Please, upgrade your browser.
AGEN Agenus Inc. daily Stock Chart
Agenus Inc.
Index- P/E- EPS (ttm)-1.48 Insider Own18.81% Shs Outstand115.61M Perf Week-8.59%
Market Cap209.25M Forward P/E- EPS next Y-1.46 Insider Trans0.00% Shs Float91.97M Perf Month-9.50%
Income-150.90M PEG- EPS next Q-0.25 Inst Own35.90% Short Float12.82% Perf Quarter-6.70%
Sales29.20M P/S7.17 EPS this Y15.90% Inst Trans0.02% Short Ratio8.71 Perf Half Y-49.72%
Book/sh-1.07 P/B- EPS next Y-11.50% ROA-109.70% Target Price7.00 Perf Year-58.20%
Cash/sh- P/C- EPS next 5Y- ROE170.70% 52W Range1.55 - 6.19 Perf YTD-44.48%
Dividend- P/FCF- EPS past 5Y-19.10% ROI-119.00% 52W High-70.76% Beta1.94
Dividend %- Quick Ratio1.30 Sales past 5Y21.90% Gross Margin- 52W Low16.77% ATR0.15
Employees255 Current Ratio1.30 Sales Q/Q278.60% Oper. Margin- RSI (14)37.16 Volatility6.79% 7.33%
OptionableYes Debt/Eq- EPS Q/Q26.50% Profit Margin- Rel Volume0.90 Prev Close1.81
ShortableYes LT Debt/Eq- EarningsNov 06 BMO Payout- Avg Volume1.35M Price1.81
Recom1.00 SMA20-11.69% SMA50-9.55% SMA200-43.49% Volume600,154 Change0.00%
Oct-28-16Downgrade H.C. Wainwright Buy → Neutral $10 → $5
Oct-27-16Reiterated Maxim Group Buy
Mar-11-16Upgrade Maxim Group Hold → Buy $7
Dec-16-15Initiated Jefferies Buy
Oct-27-15Downgrade Maxim Group Buy → Hold
Jul-27-15Reiterated MLV & Co Buy $9 → $11
Jun-11-15Initiated Oppenheimer Outperform $14
Jan-12-15Reiterated Maxim Group Buy $10 → $11
Jan-09-15Reiterated MLV & Co Buy $6 → $9
Jan-09-15Reiterated Maxim Group Buy $10 → $11
Dec-19-14Reiterated Maxim Group Buy $8 → $10
May-08-14Reiterated Maxim Group Buy $17 → $11
Mar-14-14Reiterated MLV & Co Buy $9 → $11
Oct-08-13Reiterated Maxim Group Buy $19
Jan-05-12Initiated William Blair Outperform
Dec-01-11Initiated Global Hunter Securities Buy $6
Oct-20-18 07:30AM  Agenus Presents Clinical Data on Its PD-1 & CTLA-4 at ESMO 2018 PR Newswire
Oct-09-18 09:00AM  Agenus To Present Data on Proprietary CTLA-4 & PD-1 Antibodies at ESMO 2018 PR Newswire
Oct-08-18 08:25AM  Recent Analysis Shows Ryman Hospitality Properties, PennantPark Investment, PS Business Parks, Agenus, Belden, and Robert Half International Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-05-18 08:48AM  Celyad (CYAD) Jumps: Stock Rises 6.8% Zacks
Sep-28-18 08:38AM  Agenus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York, NY PR Newswire
Sep-21-18 07:00AM  Agenus Closes $15 Million Partial Royalty Monetization With XOMA PR Newswire
Sep-19-18 09:27AM  How Does Investing In Agenus Inc (NASDAQ:AGEN) Impact Your Portfolio? Simply Wall St.
Sep-18-18 06:18PM  Agenus Receives Milestone Payment of $5 Million from Incyte Zacks
Sep-17-18 09:00AM  Agenus Receives Milestone Payment from Incyte PR Newswire -7.11%
Sep-14-18 08:57AM  Implied Volatility Surging for Agenus (AGEN) Stock Options Zacks
Sep-07-18 07:32AM  Why Agenus' Stock Perked Up in August Motley Fool
Sep-05-18 07:34PM  AgenTus Therapeutics to Present on the Anti-tumor Activities of Two Proprietary T Cell Receptors (TCRs) at CAR-TCR Summit in Boston, MA PR Newswire
Sep-04-18 09:57AM  Agenus to Present at The Annual B. Riley FBR Healthcare Conference in New York City PR Newswire
Aug-31-18 04:30AM  Agenus (AGEN) Continue to Surge Higher? Zacks +5.24%
Aug-27-18 09:55AM  Edited Transcript of AGEN earnings conference call or presentation 9-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-23-18 10:00AM  Is Agenus Inc. Stock a Buy? Motley Fool
Aug-17-18 07:39AM featured highlights include: Dollar Tree, Agenus, Huntsman, ArcelorMittal and International Paper Zacks
Aug-16-18 08:42AM  Step Beyond Bargain Hunting & Tap Rising P/E With 5 Stocks Zacks
Aug-15-18 01:22PM  Agenus Receives Second Milestone Payment from Merck PR Newswire -5.59%
09:56AM  Agenus (AGEN) Delivering Well on Its Pipeline Candidates Zacks
Aug-10-18 09:32AM  Agenus' (AGEN) Q2 Loss Narrower Than Expected, Revenues Beat Zacks
Aug-09-18 10:55AM  Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates Zacks
09:52AM  Agenus: 2Q Earnings Snapshot Associated Press
09:42AM  Agenus (AGEN) Reports Narrower than Expected Loss in Q2 Zacks
08:00AM  Agenus Reports Second Quarter 2018 Financial Results and Provides Corporate Update PR Newswire
06:30AM  Agenus Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 02:00PM  Agenus to Report Second Quarter 2018 Financial Results on August 9, 2018 and Host Conference Call and Webcast PR Newswire
Jul-30-18 03:55PM  Will Agenus (AGEN) Disappoint Investors This Earnings Season? Zacks +5.08%
Jul-27-18 07:45AM  New Research: Key Drivers of Growth for Cadence Design, Agenus, Foundation Medicine, Honeywell International, NeoPhotonics, and Citrix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jul-21-18 08:25AM  Should Biotech Investors Fear Dilution? Motley Fool
Jul-17-18 08:37AM  Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4 Benzinga
Jul-16-18 08:37AM  Agenus Appoints Regulatory and Clinical Heads PR Newswire -5.02%
Jun-20-18 08:00AM  Agenus to Webcast Annual Meeting of Stockholders PR Newswire +9.49%
Jun-18-18 06:30AM  National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up CNW Group
Jun-12-18 08:30AM  Agenus Discovery Enhances Activity of Cancer Fighting Antibodies; Findings Published in Cancer Cell PR Newswire
Jun-11-18 07:40AM  Todays Free Research Reports Coverage on Agenus and Three More Biotech Stocks ACCESSWIRE -6.13%
Jun-06-18 01:00PM  Agenus to Present at the Jefferies 2018 Global Healthcare Conference in New York, NY PR Newswire
08:17AM  Agenus (AGEN) Down 1.5% Since Earnings Report: Can It Rebound? Zacks
Jun-04-18 01:35PM  Agenus Presents Clinical Responses of AGEN1884 (anti-CTLA-4) and AGEN2034 (anti-PD-1) at ASCO 2018 PR Newswire
Jun-03-18 07:27PM  The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines Benzinga
May-17-18 01:37PM  Agenus to Present Clinical Data on Lead Programs at ASCO 2018 PR Newswire
May-12-18 09:28AM  Is Agenus Inc. (AGEN) a Buy? Motley Fool
May-09-18 11:46PM  Edited Transcript of AGEN earnings conference call or presentation 7-May-18 3:00pm GMT Thomson Reuters StreetEvents +7.91%
07:48AM  Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway Benzinga
May-08-18 03:59PM  Agenus' (AGEN) Q1 Loss Wider than Expected, Shares Down Zacks
May-07-18 01:00PM  Agenus to Present at Deutsche Bank's 43rd Annual Health Care Conference in Boston PR Newswire -9.78%
09:13AM  Agenus: 1Q Earnings Snapshot Associated Press
09:00AM  Agenus Reports First Quarter 2018 Financial Results and Provides Corporate Update PR Newswire
08:15AM  Agenus Inc. to Host Earnings Call ACCESSWIRE
May-05-18 09:16AM  2 Beaten-Down Biotech Stocks That Look Like Bargains Now Motley Fool
May-03-18 09:00AM  Agenus to Report First Quarter 2018 Financial Results on May 7, 2018 and Host Conference Call and Webcast PR Newswire
May-01-18 08:00AM  AgenTus Therapeutics to Present on Novel TCR Platform and Progress at PEGS Summit in Boston, MA PR Newswire
Apr-30-18 10:57AM  Will Agenus (AGEN) Disappoint Investors This Earnings Season? Zacks
Apr-16-18 03:20AM  Why Is Agenus (AGEN) Down 17.7% Since its Last Earnings Report? Zacks -11.61%
Apr-11-18 04:07PM  Will Agenus Incs (NASDAQ:AGEN) Earnings Grow Over The Next Few Years? Simply Wall St.
10:00AM  Three Agenus Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) 2018 Annual Meeting PR Newswire
Mar-29-18 08:30AM  Agenus to Present at Healthcare Investor Conferences In April PR Newswire
Mar-16-18 10:31AM  Agenus (AGEN) Q4 Loss Wider Than Expected, Revenues Miss Zacks +5.61%
02:34AM  Edited Transcript of AGEN earnings conference call or presentation 15-Mar-18 3:00pm GMT Thomson Reuters StreetEvents
Mar-15-18 10:09AM  Agenus (AGEN) Reports Wider than Expected Q4 Loss, Sales Miss Zacks
08:45AM  Agenus reports 4Q loss Associated Press
08:30AM  Agenus Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update PR Newswire
07:45AM  Agenus Inc. to Host Earnings Call ACCESSWIRE
Mar-07-18 10:19AM  Steven Cohen Takes Stake in Biotech Company Agenus
08:00AM  Agenus to Report Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018 and Host Conference Call and Webcast PR Newswire
Mar-06-18 01:31PM  Has Agenus Inc (NASDAQ:AGEN) Improved Earnings Growth In Recent Times? Simply Wall St.
Feb-28-18 09:42AM  4 Market-Beating Sector ETFs & Stocks of February Zacks
Feb-21-18 08:48AM  Why Agenus Stock Spiked Tuesday Motley Fool
08:31AM  What's in Store for Agenus (AGEN) This Earnings Season? Zacks
08:00AM  New Research Coverage Highlights Acacia Research, Zebra Technologies, VSE, Spectrum Pharmaceuticals, Agenus, and Williams Companies Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Feb-13-18 07:31AM  Is Agenus Inc. a Buy? Motley Fool
Jan-22-18 10:00AM  Agenus Announces Combination Clinical Trials of its Anti-CTLA4 (AGEN1884) & Anti-PD1 (AGEN2034) PR Newswire
07:00AM  Agenus Inc. Closes $230 Million Royalty Monetization with HealthCare Royalty Partners PR Newswire
Jan-18-18 01:55PM  3 Biotech Stocks Start Healthy in 18: Will the Rally Last? InvestorPlace
Jan-17-18 08:23AM  BlackRock, Pier One Imports, Alkermes, Vertex Pharmaceuticals and Agenus highlighted as Zacks Bull and Bear of the Day Zacks
Jan-16-18 03:11PM  3 Biotech Stocks Start Healthy in '18: Will the Rally Last? Zacks
10:00AM  Will 2018 Be Agenus Inc.'s Best Year Yet? Motley Fool
Jan-09-18 08:48AM  Agenus Inc., (AGEN) Jumps: Stock Rises 11.4% Zacks
Jan-08-18 08:32AM  Agenus Inc. Announces $230 Million Royalty Monetization with HealthCare Royalty Partners PR Newswire +11.40%
Jan-06-18 08:00AM  Why Agenus Inc. Stock Sank in December Motley Fool
Jan-04-18 07:30AM  Agenus' Dr. John Castle Joins Thought Leadership Panel on I-O Combinations at 10th Annual Biotech Showcase 2018 PR Newswire
Jan-03-18 07:00AM  Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings PR Newswire
Jan-02-18 11:01AM  ETFs with exposure to Agenus, Inc. : January 2, 2018 Capital Cube +8.59%
Dec-22-17 11:30AM  ETFs with exposure to Agenus, Inc. : December 22, 2017 Capital Cube
Dec-11-17 01:22PM  ETFs with exposure to Agenus, Inc. : December 11, 2017 Capital Cube
Dec-01-17 06:50PM  Agenus Inc (AGEN)s Earnings Grew 12.7%, Is It Enough? Simply Wall St.
Nov-30-17 01:12PM  ETFs with exposure to Agenus, Inc. : November 30, 2017 Capital Cube
Nov-29-17 08:41AM  Agenus, Inc. :AGEN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube
Nov-24-17 08:00AM  Todays Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Agenus Inc. ACCESSWIRE
Nov-15-17 09:25AM  Agenus Receives License Fee of $4 Million USD from Merck PR Newswire
Nov-09-17 08:45AM  Agenus To Present on Lead Antibody Programs AGEN1884 (CTLA-4) and AGEN2034 (PD-1) at SITC 2017 PR Newswire
Nov-08-17 02:12PM  Agenus to Present at the Jefferies Global Healthcare Conference in London PR Newswire
11:56AM  Agenus (AGEN) Reports In Line Loss in Q3, Revenues Lag Zacks
09:45AM  Prothena (PRTA) Earnings Beat in Q3, Pipeline in Focus Zacks
Nov-07-17 04:50PM  Edited Transcript of AGEN earnings conference call or presentation 7-Nov-17 4:00pm GMT Thomson Reuters StreetEvents
10:49AM  Agenus (AGEN) Reports In Line Q3 Loss, Sales Miss Estimates Zacks
09:35AM  Agenus reports 3Q loss Associated Press
09:22AM  Agenus Reports Third Quarter 2017 Financial Results and Provides Corporate Update PR Newswire
09:19AM  Endocyte (ECYT) Posts Narrower-than-Expected Q3 Loss Zacks
09:00AM  Agenus Inc. to Host Earnings Call ACCESSWIRE
Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; SECANT yeast display, an antibody discovery platform used for the generation of novel monoclonal antibodies; and phage display technologies. It is also developing checkpoint modulating antibody candidates targeting GITR, OX40, TIM-3, LAG-3, and others. In addition, the company develops vaccine programs, including Prophage cancer vaccine candidate; AutoSynVax, a synthetic neo-antigen; and PhosPhoSynVax, a vaccine candidate designed to induce immunity against a class of tumor specific neo-epitopes. Further, it develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. Additionally, the company engages in the development of CTLA-4 and PD-1 antagonists; and anti-CTLA-4, CD137, and anti-TIGIT antibodies, as well as various multi-specific antibodies that are under various stages of development. Agenus Inc. has collaboration agreements with Incyte Corporation, Merck Sharpe & Dohme, and Recepta Biopharma SA. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Duncan AlexChief Technology OfficerDec 12Sale3.466,54622,65121,026Dec 14 04:27 PM
KLASKIN CHRISTINE MVP, FinanceDec 12Sale3.465,61019,41864,333Dec 14 04:21 PM
Baysal OzerChief Commercial OfficerDec 12Sale3.463,71212,84658,790Dec 14 04:38 PM
Buell JenniferChief Communications OfficerDec 12Sale3.463,51112,15235,656Dec 14 04:33 PM
Valentine KarenChief Legal OfficerDec 12Sale3.468,35828,921101,521Dec 14 04:14 PM